Project 8p Research Newsletter – April 2024

Project 8p initiated a collaboration with Dr Francesca Telese at the UCSD to tackle that thorny question. Dr Yanning Zuo, a postdoctoral fellow in the Telese lab, joined the 8p Research Roundtable last month to present updates on a comprehensive bioinformatics analysis of a massive, first-of-its-kind, single-cell RNA sequencing (scRNASeq) experiment on a 8p family trio of cortical brain organoids.

The organoids were grown for up to nine months in culture by brain organoid pioneer Dr. Alysson Muotri, whose lab is also located at UCSD. Dr. Muotri’s 8p Research Roundtable talk from January 2023 can be viewed here. Recall that his lab performed a preliminary analysis on the 8p brain organoid scRNASeq dataset that revealed a striking result that comes with a 
”single-proband, single-clone” proviso.

A peculiar population of Reelin-expressing neurons was present in the 8p hero brain organoids but not in brain organoids derived from either parent. Are these the fabled Cajal-Retzius neurons that are thought to exclusively express Reelin? Or are they something else entirely?

CONTINUE READING

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.